| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.27▼ | 0.27▼ | 0.27▼ | 0.27▼ | 0.28▼ |
| MA10 | 0.28▼ | 0.27▼ | 0.27▼ | 0.27▼ | 0.31▼ |
| MA20 | 0.27▼ | 0.27▼ | 0.27▼ | 0.28▼ | 0.53▼ |
| MA50 | 0.27▼ | 0.27▼ | 0.27▼ | 0.34▼ | 0.89▼ |
| MA100 | 0.27▼ | 0.28▼ | 0.27▼ | 0.59▼ | 1.55▼ |
| MA200 | 0.28▼ | 0.27▼ | 0.31▼ | 0.87▼ | 5.54▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.001▲ | 0.001▲ | 0.007▲ | -0.002▼ |
| RSI | 39.400▼ | 45.774▼ | 46.207▼ | 38.694▼ | 27.610▼ |
| STOCH | 47.992 | 78.603 | 62.530 | 34.405 | 12.914▼ |
| WILL %R | -100.000▼ | -60.814 | -55.390 | -74.833 | -92.398▼ |
| CCI | -359.099▼ | -37.075 | 25.727 | -62.644 | -69.595 |
|
Friday, January 09, 2026 12:59 AM
TAMPA, Fla. and LONDON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payloads for antibody drug conjugates (ADCs), today ...
|
|
Thursday, January 08, 2026 06:15 AM
Akari Therapeutics is an oncology biotechnology company developing next-generation antibody drug conjugates (ADCs) with a unique payload, PH1, which targets RNA splicing. Utilizing its innovative ADC ...
|
|
Tuesday, December 30, 2025 06:15 AM
As 2025 concludes, I am pleased to reflect on a year of meaningful progress and significant achievements towards creating best-in-class ADCs to transform current cancer therapies. With each forward ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/01/26 | 0.2747 | 0.2747 | 0.2651 | 0.2651 | 954,258 |
| 23/01/26 | 0.279 | 0.28 | 0.2531 | 0.2736 | 353,143 |
| 22/01/26 | 0.252 | 0.284 | 0.252 | 0.2684 | 497,834 |
| 21/01/26 | 0.268 | 0.268 | 0.25 | 0.261 | 248,000 |
| 20/01/26 | 0.2684 | 0.2774 | 0.26 | 0.2639 | 88,072 |
| 16/01/26 | 0.279 | 0.2879 | 0.2675 | 0.2806 | 310,360 |
| 15/01/26 | 0.269 | 0.28 | 0.2601 | 0.2673 | 300,459 |
| 14/01/26 | 0.28 | 0.285 | 0.267 | 0.268 | 238,600 |
| 13/01/26 | 0.284 | 0.287 | 0.275 | 0.279 | 217,400 |
| 12/01/26 | 0.29 | 0.29 | 0.275 | 0.275 | 351,000 |
|
|
||||
|
|
||||
|
|